Cardinal Health stock: Mizuho lifts target to USD 280.00 for Cardinal Health stock
Published on 10/21/2026 at 16:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Mizuho lifted its Cardinal Health target to USD 280.00 on October 20, 2026.
- Fiscal fourth-quarter revenue reached USD 63.67 billion, up 5.80 percent year over year.
- Cardinal Health stock costs EUR 228.40 at Lang & Schwarz on October 21, 2026 at 4:11 p.m. CEST, 0.31 percent above the Tradegate close of October 20, 2026, and 0.32 percent below the USD 258.76 52-week high.
- Cardinal Health plans to report fiscal first-quarter 2027 results on November 5, 2026.
Cardinal Health (US14149Y1082) became the subject of a new Mizuho target increase on October 20, 2026, when the firm lifted its objective from USD 250.00 to USD 280.00 and maintained an outperform rating, as MarketBeat reported. That target stood 8.56 percent above Cardinal Health's USD 257.92 primary-market price at 10:25 a.m. ET on October 21, 2026. At 4:11 p.m. CEST on October 21, 2026, the stock was trading at EUR 228.40 at Lang & Schwarz, 0.31 percent above the Tradegate close of October 20, 2026 at EUR 227.70.
Revenue reached USD 63.67 billion
Cardinal Health's fiscal fourth-quarter revenue rose 5.80 percent year over year to USD 63.67 billion, while earnings per share came in at USD 2.91 against a USD 2.42 consensus estimate, according to MarketBeat. Revenue nevertheless fell short of the USD 65.15 billion estimate in that fiscal quarter. Management set fiscal 2027 adjusted earnings-per-share guidance at USD 12.40-12.60.
Stock sits 0.32 percent below its high
The primary-market quote was USD 257.92 on October 21, 2026 at 10:25 a.m. ET, with a session range of USD 254.74 to USD 258.75 and volume of 183,189 shares. The 52-week range was USD 157.79 to USD 258.76, leaving the price 0.32 percent below the high. Cardinal Health had a market capitalization of USD 59.7 billion and a price-to-earnings ratio of 35.68 at that snapshot.
Valuation and November 5 results
The next scheduled company event is fiscal first-quarter 2027 results on November 5, 2026, before trading opens in New York, followed by an 8:30 a.m. ET webcast. The date was announced by Cardinal Health on October 1, 2026. The upcoming report will test whether the USD 12.40-12.60 adjusted earnings-per-share outlook remains aligned with the latest operating performance.
Comparison with peers
Cardinal Health: up 0.31 percent versus the Tradegate close, P/E 35.68, market capitalization USD 59.7 billion on October 21, 2026.
McKesson Corporation (NYSE, USD): down 1.14 percent, P/E 27.24, market capitalization USD 118.7 billion on October 21, 2026.
Cencora (NYSE, USD): down 0.67 percent, P/E 25.34, market capitalization USD 65.1 billion on October 21, 2026.
Tradegate close sets the daily base
The euro quotation was EUR 228.40 at Lang & Schwarz on October 21, 2026 at 4:11 p.m. CEST, up 0.31 percent versus the Tradegate close of October 20, 2026 at EUR 227.70. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.
Cardinal Health market data
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- Ticker: CAH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 21, 2026, 4:11 p.m. CEST): EUR 228.40
- Change versus Tradegate close: plus 0.31 percent
- Tradegate close (October 20, 2026): EUR 227.70
- Market capitalization: USD 59.7 billion (as of October 21, 2026)
- 52-week range: USD 157.79-258.76 (as of October 21, 2026)
- Sector / Industry: Healthcare / Medical - Distribution
Market context: Market report S&P 500.
